Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Cynthia, Kornegay"'
Publikováno v:
Pharmacoepidemiology
Autor:
Chih-Ying Pratt, Judy A. Staffa, David Tyler Coyle, Josephine Ocran-Appiah, Cynthia Kornegay, Alex Secora
Publikováno v:
Pharmacoepidemiology and Drug Safety. 27:464-472
PURPOSE: Despite the rise in serious adverse events paralleling increased prescription opioid analgesic use in the United States over the past 2 decades, the association between opioid analgesic dose and the risk of serious adverse health outcomes is
Autor:
Elizabeth C. Dee, Jennifer Popovic, Marc R. Larochelle, Noelle M. Cocoros, Cynthia Kornegay, Jing Ju, Judith A. Racoosin
Publikováno v:
Journal of Opioid Management. 13:341-524
Objective: A risk evaluation and mitigation strategy for extended-release and long-acting (ER/LA) opioid analgesics was approved by the Food and Drug Administration in 2012. Our objective was to assess frequency of opioid tolerance and urine drug tes
Autor:
Marc R. Larochelle, MD, MPH, Noelle M. Cocoros, DSc, MPH, Jennifer Popovic, DVM, MA, Elizabeth C. Dee, MPH, Cynthia Kornegay, PhD, Jing Ju, PharmD, PhD, Judith A. Racoosin, MD, MPH
Publikováno v:
Journal of Opioid Management. 13:315-327
Objective: A risk evaluation and mitigation strategy for extended-release and long-acting (ER/LA) opioid analgesics was approved by the Food and Drug Administration in 2012. Our objective was to assess frequency of opioid tolerance and urine drug tes
Autor:
Marc R. Larochelle, Andrew B. Petrone, Jennifer R. Popovic, Cynthia Kornegay, Noelle M. Cocoros, Jing Ju, Judith A. Racoosin
Publikováno v:
Pharmacoepidemiology and drug safety. 28(1)
PURPOSE Fentanyl transdermal system (FTS) is intended only for patients with prior opioid tolerance. The purpose of this study is to identify the proportion of new FTS users who had evidence of prior opioid tolerance, by dosage strength, in FDA's Sen
Autor:
Marc R, Larochelle, Noelle M, Cocoros, Jennifer, Popovic, Elizabeth C, Dee, Cynthia, Kornegay, Jing, Ju, Judith A, Racoosin
Publikováno v:
Journal of opioid management. 13(5)
A risk evaluation and mitigation strategy for extended-release and long-acting (ER/LA) opioid analgesics was approved by the Food and Drug Administration in 2012. Our objective was to assess frequency of opioid tolerance and urine drug testing for in
Autor:
Eugenio Andraca-Carrera, Peter S. Miele, Kendall A. Marcus, Charles K. Cooper, Cynthia Kornegay, Xiao Ding, Mat Soukup
Publikováno v:
JAIDS Journal of Acquired Immune Deficiency Syndromes. 61:441-447
BACKGROUND Several studies have reported an association between abacavir (ABC) exposure and increased risk of myocardial infarction (MI) among HIV-infected individuals. Randomized controlled trials (RCTs) and a pooled analysis by GlaxoSmithKline, how
Autor:
Catherine S. Hwang, Cynthia Kornegay, Yulan Ding, Josephine Ocran-Appiah, Judy A. Staffa, Elizabeth M. Kang, Jana K. McAninch, Tamra Meyer
Publikováno v:
JAMA Network Open
Key Points Question What percentage of patients receiving long-term immediate-release (IR) opioid analgesic therapy in the United States adds or switches to an extended-release/long-acting (ER/LA) formulation? Findings In this cohort study, most pati
Publikováno v:
The Journal of Clinical Psychiatry. 63:758-762
Background: Recent reports suggest an association between antipsychotic use and development or exacerbation of diabetes. This study evaluated the risk of incident diabetes associated with the use of atypical and conventional antipsychotics. Method: T
Autor:
David J, Graham, Kunthel, By, Stephen, McKean, Andrew, Mosholder, Cynthia, Kornegay, Judith A, Racoosin, Jessica, Young, Mark, Levenson, Thomas E, MaCurdy, Chris, Worrall, Jeffrey A, Kelman
Publikováno v:
Pharmacoepidemiology and drug safety. 23(11)
To compare cardiovascular and mortality risks in elderly patients treated with varenicline or bupropion for smoking cessation.Elderly Medicare beneficiaries were entered into new-user cohorts of varenicline or bupropion for smoking cessation and foll